lenalidomide has been researched along with Bacterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bici, A; Nachar, VR; Pianko, MJ | 1 |
| Arcaini, L; Defrancesco, I | 1 |
1 review(s) available for lenalidomide and Bacterial Disease
| Article | Year |
|---|---|
Overview on the management of non-gastric MALT lymphomas.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Chemoradiotherapy; Doxycycline; Humans; Lenalidomide; Lymphoma, B-Cell, Marginal Zone; Rituximab | 2018 |
1 other study(ies) available for lenalidomide and Bacterial Disease
| Article | Year |
|---|---|
Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bortezomib; Cohort Studies; Dexamethasone; Humans; Incidence; Infant; Lenalidomide; Multiple Myeloma; Retrospective Studies; Risk Factors | 2023 |